Skip to main content

Diagnostic options Β· UAE

Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 376–390 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-1554
Homologous Recombination Deficiency (HRD) Genomic Signature Testing Test

This test evaluates tumor DNA for genomic instability markers indicative of homologous recombination deficiency.

Tumor tissue (FFPE or fresh) + Peripheral blood (EDTA) 3-4 Weeks 36,000.00 AED
View
View test specifications and preparation
What it measures
["Loss of heterozygosity (LOH)", "Telomeric allelic imbalance (TAI)", "Large-scale state transitions (LST)", "BRCA1/2 mutation status"]
Parameters
[]
Preparation
["No special fasting or medication changes are required unless directed by your physician.", "A valid doctor’s prescription is required (except for surgery or pregnancy cases)."]
Indications
["Guiding targeted therapy selection (e.g., PARP inhibitors)", "Evaluating cancer susceptibility", "Patients with breast, ovarian, pancreatic, or prostate cancer"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96791-6 ICD-10: Z01.818, C50.9, C56
Clinical summary
This test evaluates tumor DNA for genomic instability markers indicative of homologous recombination deficiency.
TEST-547
Hospital Baby Exchange Maternity DNA Test

This test confirms or excludes biological maternity by comparing genetic markers between the child and alleged parents.

Peripheral Whole Blood or Buccal Epithelial Cells 10 Working Days 1,500.00 AED
View
View test specifications and preparation
What it measures
["Short Tandem Repeats (STRs)", "Genetic Markers"]
Parameters
[]
Preparation
[]
Indications
["Suspected newborn exchange in a hospital", "Need for legally admissible maternity confirmation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 4532-3 ICD-10: Z02.4
Clinical summary
This test confirms or excludes biological maternity by comparing genetic markers between the child and alleged parents.
TEST-1691
HPV Detection & Genotyping (Qualitative PCR) Test

This test detects the presence of high-risk HPV DNA and identifies specific oncogenic genotypes (like 16 and 18) in patient samples.

Cervical swab, oral swab, or tissue biopsy 2 business days (collection on Wed/Sat; results reported on Sun/Thu respectively) 650.00 AED
View
View test specifications and preparation
What it measures
["High-risk HPV DNA", "HPV Genotypes (16, 18, other oncogenic types)"]
Parameters
[]
Preparation
["For cervical swabs: Avoid intercourse, douching, or using vaginal medications for 48 hours before collection.", "For oral swabs: Avoid eating or drinking 30 minutes prior.", "No fasting is required."]
Indications
["Cancer screening", "Risk assessment for HPV-related cancers", "Guiding screening intervals", "Informing vaccination strategies", "Targeted follow-up"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21414-1 ICD-10: Z11.51
Clinical summary
This test detects the presence of high-risk HPV DNA and identifies specific oncogenic genotypes (like 16 and 18) in patient samples.
TEST-5006
HR Gene Hypotrichosis Type 4 Genetic Test

This test identifies pathogenic variants in the HR gene, which are responsible for autosomal recessive hypotrichosis type 4, a form of inherited hair loss.

Whole blood (EDTA), FTA card, or extracted DNA (β‰₯200 ng) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["HR gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Continue prescribed medications unless advised otherwise"]
Indications
["Suspected autosomal recessive hypotrichosis type 4", "Differential diagnosis of alopecia", "Genetic counselling for inherited hair loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 87710-3 ICD-10: Q84.0
Clinical summary
This test identifies pathogenic variants in the HR gene, which are responsible for autosomal recessive hypotrichosis type 4, a form of inherited hair loss.
TEST-4082
HSPB8 Gene (CMT2L) Next-Generation Sequencing (NGS) Genetic Test

This diagnostic test evaluates the HSPB8 gene for pathogenic variants associated with Charcot-Marie-Tooth disease type 2L (CMT2L).

Whole blood (EDTA) or extracted DNA sample 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the HSPB8 gene coding region"]
Parameters
[]
Preparation
["Do not discontinue prescribed medication without consulting your doctor.", "Inform your healthcare provider of all medications and supplements."]
Indications
["Suspected Charcot-Marie-Tooth disease type 2L (CMT2L)", "Family history of CMT2L", "Need for definitive genetic diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82622-1 ICD-10: G60.0
Clinical summary
This diagnostic test evaluates the HSPB8 gene for pathogenic variants associated with Charcot-Marie-Tooth disease type 2L (CMT2L).
TEST-802
hTERT RNA Qualitative Detection (qPCR) Test

This test detects the presence of hTERT mRNA, a biomarker associated with telomerase activity, often elevated in certain cancers.

Urine, Pancreatic Juice, Bone Marrow Aspirate Results by Email: 36 hours; Phone: 24 hours 900.00 AED
View
View test specifications and preparation
What it measures
["hTERT mRNA expression", "Telomerase activity"]
Parameters
[]
Preparation
[]
Indications
["Screening for malignancies (urological, pancreatic, hematological)", "Evaluation of telomerase activity as an anti-aging biomarker"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101497-1 ICD-10: Z12.9
Clinical summary
This test detects the presence of hTERT mRNA, a biomarker associated with telomerase activity, often elevated in certain cancers.
TEST-5508
HTRA2 Gene (PARK13) Parkinson Genetic Test

This test evaluates the HTRA2 gene for pathogenic variants associated with early-onset Parkinson disease.

Peripheral Whole Blood (EDTA tube) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the HTRA2 gene"]
Parameters
[]
Preparation
[]
Indications
["Screening for early-onset Parkinson disease", "Diagnosis clarification in patients with relevant symptoms or family history"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 59049-0 ICD-10: G20, G21.8
Clinical summary
This test evaluates the HTRA2 gene for pathogenic variants associated with early-onset Parkinson disease.
TEST-238
Human Bisulfite Sequencing (DNA Methylation Assay) Test

This test evaluates DNA methylation patterns across the genome using bisulfite sequencing.

Whole Blood (Peripheral) or Extracted DNA 14–21 working days 15,000.00 AED
View
View test specifications and preparation
What it measures
["DNA Methylation Levels", "Differentially Methylated Regions (DMRs)", "Biological Age Clocks"]
Parameters
[]
Preparation
["Fasting is not mandatory.", "Avoid heavy fatty meals for 4 hours before collection.", "Inform physician about all current prescriptions and supplements.", "Do not stop or change any medication without medical consultation."]
Indications
["Oncology risk stratification", "Functional medicine profiling", "Biological age assessment", "Early detection of epigenetic signatures linked to malignancy", "Metabolic dysfunction assessment", "Accelerated aging assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96534-9 ICD-10: Z12.9, Z01.89
Clinical summary
This test evaluates DNA methylation patterns across the genome using bisulfite sequencing.
TEST-276
Human Bisulfite Sequencing and Analysis Test

This test evaluates genome-wide DNA methylation patterns at single-base resolution using bisulfite sequencing.

Whole Blood or Extracted DNA (EDTA tube) 10 weeks 20,000.00 AED
View
View test specifications and preparation
What it measures
["DNA methylation patterns", "Epigenetic alterations"]
Parameters
[]
Preparation
["No fasting required", "Maintain normal hydration", "Continue all prescribed medications unless instructed otherwise by physician"]
Indications
["Early detection of malignant transformations", "Assessment of autoimmune disease risk", "Tailoring anti-aging protocols", "Monitoring disease activity in rheumatology"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95451-5 ICD-10: Z13.89
Clinical summary
This test evaluates genome-wide DNA methylation patterns at single-base resolution using bisulfite sequencing.
TEST-248
Human Exome Sequencing (Twist Core Exome Panel) Test

This test analyzes the protein-coding regions of the genome to identify genetic variants associated with hereditary diseases.

Whole Blood or Extracted DNA 5 Weeks 3,500.00 AED
View
View test specifications and preparation
What it measures
["Single-nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNVs)"]
Parameters
[{"name": "Target Enrichment", "reference_range": "Twist Bioscience Double-Stranded Capture Probes – Uniform Coverage, Minimal GC Bias"}, {"name": "Diagnostic Yield", "reference_range": "β‰₯99.9% Sensitivity for SNVs/Indels; Superior CNV Detection"}, {"name": "ISO Accreditation", "reference_range": "ISO 9001:2015 Certified (INT/EGQ/2509DA/3139)"}]
Preparation
["No fasting required", "No medication changes needed", "Inform team of recent blood transfusions or bone marrow transplants"]
Indications
["Diagnosis of hereditary cancers", "Diagnosis of inborn errors of metabolism", "Diagnosis of neurodevelopmental disorders", "Diagnosis of rare genetic syndromes"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 84473-7 ICD-10: Z13.71
Clinical summary
This test analyzes the protein-coding regions of the genome to identify genetic variants associated with hereditary diseases.
TEST-286
Human Exome Sequencing & Analysis (Twist Human Core Exome) Test

This test analyzes the protein-coding regions of DNA to identify genetic variants linked to inherited diseases, cancer risk, and autoimmune conditions.

Whole Blood (2–5 mL EDTA) or Extracted DNA (β‰₯1 Β΅g, A260/A280 1.8–2.0) 8 weeks from sample receipt 5,000.00 AED
View
View test specifications and preparation
What it measures
["Protein-coding DNA variants", "Clinically relevant genetic mutations"]
Parameters
[]
Preparation
["No special preparation needed", "Continue all prescribed medications unless advised otherwise by your doctor"]
Indications
["Diagnosis of suspected inherited genetic disorders", "Assessment of cancer predisposition", "Investigation of autoimmune disorders", "Identification of variants in protein-coding regions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94547-8 ICD-10: Z13.71
Clinical summary
This test analyzes the protein-coding regions of DNA to identify genetic variants linked to inherited diseases, cancer risk, and autoimmune conditions.
TEST-255
Human Exome Sequencing Test

This test analyzes the exome, the protein-coding portion of the genome, to identify disease-causing genetic variants.

Whole blood (3 mL in EDTA tube) or Extracted DNA (3 Β΅g) 5 weeks 4,000.00 AED
View
View test specifications and preparation
What it measures
["Protein-coding regions (exons)", "Pathogenic variants"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Diagnosis of suspected monogenic disorders", "Identification of variants in patients with complex or undiagnosed conditions", "Carrier screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94114-5 ICD-10: Z13.71, Z13.89
Clinical summary
This test analyzes the exome, the protein-coding portion of the genome, to identify disease-causing genetic variants.
TEST-860
Human Papillomavirus (HPV) 16 & 18 RNA Detection, Qualitative Test

This test detects the presence of active HPV 16 and 18 RNA, indicating ongoing viral replication associated with a higher risk of cervical precancer.

Cervical Swab 24 – 36 hours 750.00 AED
View
View test specifications and preparation
What it measures
["HPV 16 E6/E7 mRNA", "HPV 18 E6/E7 mRNA"]
Parameters
[]
Preparation
["Avoid sexual intercourse for 48 hours prior", "Avoid douching for 48 hours prior", "Avoid vaginal medications/tampons for 48 hours prior", "Reschedule if heavy menstrual bleeding"]
Indications
["Triage of ASC-US cytology", "Screening for high-risk HPV 16/18", "Evaluation of persistent HPV infection"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 80380-7 ICD-10: Z11.51, R87.810, Z15.89
Clinical summary
This test detects the presence of active HPV 16 and 18 RNA, indicating ongoing viral replication associated with a higher risk of cervical precancer.
TEST-1491
Human Papillomavirus (HPV) Genotyping Test

This test identifies the specific genotypes of Human Papillomavirus (HPV) present in a cervical swab sample.

Cervical Swab 4 – 5 working days 1,000.00 AED
View
View test specifications and preparation
What it measures
["High-risk HPV genotypes (e.g., 16, 18, 31, 33, 45, 52, 58)", "Low-risk HPV genotypes (e.g., 6, 11)"]
Parameters
[]
Preparation
["Avoid vaginal intercourse, douching, or intravaginal products for 48 hours before sample collection.", "Inform the phlebotomist of any menstrual spotting or recent cervical procedures."]
Indications
["Screening for high-risk HPV types", "Risk stratification for cervical cancer", "Post-treatment monitoring"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21440-3, 43304-8 ICD-10: Z11.51, B97.7
Clinical summary
This test identifies the specific genotypes of Human Papillomavirus (HPV) present in a cervical swab sample.
TEST-1501
Human Papillomavirus (HPV) Qualitative PCR Test

This test detects the presence or absence of high-risk Human Papillomavirus (HPV) DNA in a sample.

Cervical swab, FFPE tissue blocks 2–3 working days 750.00 AED
View
View test specifications and preparation
What it measures
["Presence of high-risk HPV DNA"]
Parameters
[]
Preparation
["Avoid vaginal intercourse, douching, and intravaginal medications for 48 hours before the cervical swab."]
Indications
["Cervical cancer screening", "Post-treatment surveillance for cervical abnormalities", "Evaluation of abnormal Pap smear results"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 77399-4 ICD-10: Z11.51, R87.81, B97.7
Clinical summary
This test detects the presence or absence of high-risk Human Papillomavirus (HPV) DNA in a sample.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area